JointMetrix Medical Presents Novel Joint Monitoring Technology
SEATTLE , Jan. 28, 2013 /PRNewswire/ -- JointMetrix Medical has developed novel remote monitoring technology for use in conjunction with joint replacement surgery. An abstract describing use of the system was presented today at the 2013 Meeting of the Orthopaedic Research Society in San Antonio, TX.
The system was developed by JointMetrix Medical in collaboration with a team of clinicians and researchers at University of Washington's Department of Orthopaedics and Sports Medicine. Several leading US Orthopaedic centers are preparing research initiatives that leverage the system, which is expected to be commercially released later in 2013.
JointMetrix Medical's remote monitoring technology enables continuous and accurate measurement of patients' joint motion and overall activity, providing a breakthrough in clinicians' ability to track and positively influence post-surgical outcomes.
"Remote monitoring will be an important element of care in Orthopaedics, allowing clinicians to more appropriately select and care for their patients," said Dave Marver, CEO, JointMetrix Medical. "The data our system provides will allow earlier and more effective intervention while providing much needed efficiencies for busy surgeons and their staffs." About JointMetrix Medical JointMetrix Medical, LLC was created to commercialize technology developed by Peter Cavanagh, Ph.D., D.Sc., former Chairman of Biomedical Engineering at Cleveland Clinic and current Vice Chair for Research in the Department of Orthopaedics and Sports Medicine at University of Washington. Dr. Cavanagh developed JointMetrix Medical's underlying technology over the last decade in connection with NASA-sponsored research to measure astronauts' activity aboard the International Space Station. The company is pioneering clinical use of remote monitoring in Orthopaedics. Its first product, a system intended for use in conjunction with total knee arthroplasty, is expected to be commercially released in the US in 2013.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
